<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03991156</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-47864</org_study_id>
    <secondary_id>PEDSVAR0050</secondary_id>
    <secondary_id>IRB-47864</secondary_id>
    <nct_id>NCT03991156</nct_id>
  </id_info>
  <brief_title>AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study</brief_title>
  <official_title>AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the success rate of the AVATAR audio-visual system. All patients enrolled in the
      study will be counted, and each patient who is able to undergo at least one fraction without
      anesthesia will count as a success while each patient who does not have at least one fraction
      without anesthesia will count as a failure. The success rate will be the proportion of
      patients who are successes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of AVATAR system</measure>
    <time_frame>24 months</time_frame>
    <description>Success rate will be determined as the proportion of patients who are successes.
Success will be counted as each patient who is able to undergo at least one fraction without anesthesia while each patient who does not have at least one fraction without anesthesia will count as a failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure Fractional Success using AVATAR system</measure>
    <time_frame>24 months</time_frame>
    <description>Fractional Success will be is counted as a fraction in which the patient does not require anesthesia will count as a fractional success, while a fraction in which the patient required anesthesia will be a fractional failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the difference in patient anxiety between successful AVATAR patients and not-successful patients.</measure>
    <time_frame>24 months</time_frame>
    <description>The difference in patient anxiety between successful AVATAR patients and not-successful patients will be determined. Anxiety will be assesed by modified Yale Preoperative Anxiety Survey Short Form (mYPAS-SF). mYPAS-SF measurement instrument uses 5 items, each representing a different domain of child anxiety, and is used at 4 points in time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the rates of anesthesia with historical controls</measure>
    <time_frame>24 months</time_frame>
    <description>Compare the rates of anesthesia use between patients using AVATAR to historical controls who were not introduced to AVATAR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the rate at which patients convert from requiring anesthesia to not requiring anesthesia while using AVATAR</measure>
    <time_frame>24 months</time_frame>
    <description>The rate at which patients convert from requiring anesthesia to not requiring anesthesia while using AVATAR will be determined. Conversion is determined by the fraction at which the patient switches from using anesthesia to not using anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in health quality of life between subjects with or without anesthesia</measure>
    <time_frame>24 months</time_frame>
    <description>The difference between family-reported health-related quality of life between patients who were able to tolerate treatment without anesthesia using the AVATAR program and patients who required anesthesia for the entire treatment. The quality of life will be measured using Pediatric oncology quality of life inventory 3.0-cancer module (PedsQL 3.0 Cancer Module)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess predictability for AVATAR patient success</measure>
    <time_frame>24 months</time_frame>
    <description>AVATAR patient success will be determined by using the predictability of the PedsQL3.0 Cancer and modified Yale Preoperative Assessment Survey Short Form (mYPAS-SF) questionnaires. mYPAS-SF measurement instrument uses 5 items, each representing a different domain of child anxiety, and is used at 4 points in time.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Audio-Visual Assisted Therapeutic Ambience in Radiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Audio-Visual Assisted Therapeutic Ambience in Radiotherapy</intervention_name>
    <description>Audio Visual System</description>
    <arm_group_label>Audio-Visual Assisted Therapeutic Ambience in Radiotherapy</arm_group_label>
    <other_name>AVATAR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality of Life Survey, PedsQL3.0</intervention_name>
    <description>Quality of life survey using the PedsQL 3.0 Cancer Module</description>
    <arm_group_label>Audio-Visual Assisted Therapeutic Ambience in Radiotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Yale Preoperative Anxiety Scale Short Form (mYPAS-SF)</intervention_name>
    <description>Yale Preoperative Anxiety Scale Short Form (mYPAS-SF).[24] is a survey to measure anxiety</description>
    <arm_group_label>Audio-Visual Assisted Therapeutic Ambience in Radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients ages 3-10 receiving radiotherapy qualify for enrollment.

        Exclusion Criteria:

          -  Patients that are not receiving radiotherapy, and/or are out of the eligible age
             range.

          -  If radiation treatment is discontinued before 50% of the treatment plan is completed

          -  If parent/guardian is unable to take part in helping to complete questionnaires

          -  Patients with malignancies of the eye for which radiation is planned
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan M Hiniker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alice Luchen Jiang</last_name>
    <phone>650-725-4796</phone>
    <email>aj226@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Luchen Jiang</last_name>
      <phone>650-725-4796</phone>
      <email>aj226@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Holmes</last_name>
    </contact>
    <investigator>
      <last_name>Jordan Holmes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthew Ladra</last_name>
      <email>mladra@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Ladra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute/Brigham &amp; Women Children Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeremy Bredfeldt</last_name>
      <phone>617-525-7131</phone>
      <email>jbredfeldt@bwh.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minnesota</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Terazakis</last_name>
      <email>sterazak@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Stephanie Terazakis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Heimos</last_name>
      <email>hannah.heimos@bjc.org, sperkins@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Hannah Heimos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colette Shen</last_name>
      <email>colette_shen@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Colette Shen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's/UC Health Proton Therapy Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Breneman</last_name>
    </contact>
    <investigator>
      <last_name>John Breneman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blair Murphy</last_name>
      <email>murphbl@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Blair Murphy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Jude Children Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Austin Faught</last_name>
      <email>austin.faught@stjude.org</email>
    </contact>
    <investigator>
      <last_name>Austin Faught</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>June 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiotherapy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

